302 related articles for article (PubMed ID: 15147465)
1. Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?
van Goor MP; Alblas CL; Leebeek FW; Koudstaal PJ; Dippel DW
Acta Neurol Scand; 2004 Jun; 109(6):410-5. PubMed ID: 15147465
[TBL] [Abstract][Full Text] [Related]
2. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
3. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
4. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
Atanassova PA; Chalakova NT; Dimitrov BD
Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE
J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773
[TBL] [Abstract][Full Text] [Related]
6. [Ischemic stroke with antiphospholipid antibody].
Kitagawa Y; Ohkuma H; Tokuoka K
Brain Nerve; 2008 Oct; 60(10):1144-58. PubMed ID: 18975602
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study.
Ruffatti A; Del Ross T; Ciprian M; Nuzzo M; Rampudda M; Bertero MT; Bergia R; Caramaschi P; Biasi D; Capsoni F; Montaguti L; Ruffini R; Brucato A; Picillo U; Fanelli V; Riccieri V; Piccoli A; Valesini G; Doria A; Meroni PL; Tincani A
Ann Rheum Dis; 2009 Mar; 68(3):397-9. PubMed ID: 18812393
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antiphospholipid antibodies in young women with ischemic stroke.
Cojocaru IM; Cojocaru M; Burcin C; Atanasiu A
Rom J Intern Med; 2007; 45(2):201-4. PubMed ID: 18333375
[TBL] [Abstract][Full Text] [Related]
9. [Neurological aspects in antiphospholipid syndrome].
Kitagawa Y
Rinsho Shinkeigaku; 2003 Nov; 43(11):744-7. PubMed ID: 15152454
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP;
JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036
[TBL] [Abstract][Full Text] [Related]
11. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
[TBL] [Abstract][Full Text] [Related]
12. Detecting anti-prothrombin antibodies in young women with acute ischemic stroke.
Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Mitu AC; Iliescu I; Dumitrescu L; Pavel I; Silosi I
Rom J Intern Med; 2008; 46(4):337-41. PubMed ID: 19480300
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid (aPL) antibodies in end-stage renal disease.
Fabrizi F; Sangiorgio R; Pontoriero G; Corti M; Tentori F; Troina E; Locatelli F
J Nephrol; 1999; 12(2):89-94. PubMed ID: 10378664
[TBL] [Abstract][Full Text] [Related]
14. Study of antiphospholipid antibodies in type 2 diabetes mellitus with and without diabetic retinopathy.
Cojocaru IM; Cojocaru M; Popescu AN; Popescu L; Tănăsescu R
Rom J Intern Med; 2009; 47(3):267-71. PubMed ID: 20446442
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
Smith EE; Cannon CP; Murphy S; Feske SK; Schwamm LH
Am Heart J; 2006 Feb; 151(2):338-44. PubMed ID: 16442896
[TBL] [Abstract][Full Text] [Related]
17. Recurrent cerebrovascular ischaemic events in patients with interatrial septal abnormalities: a follow-up study.
Cerrato P; Priano L; Imperiale D; Bosco G; Destefanis E; Villar AM; Ribezzo M; Trevi GP; Bergamasco B; Orzan F
Neurol Sci; 2006 Feb; 26(6):411-8. PubMed ID: 16601933
[TBL] [Abstract][Full Text] [Related]
18. Anticardiolipin antibodies, recurrent stroke and vascular events: a prospective study on 210 patients.
Tănăsescu R; Ticmeanu M; Nicolau A; Uscătescu V; Cojocaru M; Grecu V; Serbănescu A
Rom J Intern Med; 2005; 43(1-2):79-88. PubMed ID: 16739868
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of antiphospholipid antibodies in Syrian patients with thrombosis.
Deeb A; Hamdoun S; Dababo K
Iran J Immunol; 2009 Sep; 6(3):154-9. PubMed ID: 19801789
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein predicts further ischemic events in transient ischemic attack patients.
Purroy F; Montaner J; Molina CA; Delgado P; Arenillas JF; Chacon P; Quintana M; Alvarez-Sabin J
Acta Neurol Scand; 2007 Jan; 115(1):60-6. PubMed ID: 17156267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
